Sign in
8-K

Current Report

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-23-217439

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d544132d8k.htm…